[Detection of Abl kinase domain point mutations in chronic myeloid leukemia patients with imatinib resistance and its clinical significance].

Gu, Hong-li

[Detection of Abl kinase domain point mutations in chronic myeloid leukemia patients with imatinib resistance and its clinical significance]. [electronic resource] - Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi Aug 2012 - 664-6 p. digital

Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.

0253-2727


Adult
Aged
Benzamides--pharmacology
Drug Resistance, Neoplasm--genetics
Humans
Imatinib Mesylate
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--genetics
Middle Aged
Piperazines--pharmacology
Point Mutation
Pyrimidines--pharmacology